MMED MiniMed Group, Inc.
Fundamentals / CIK 0002062583 / USDMiniMed Group, Inc. reported $3.10B in revenue and a net loss of $309.0M for the fiscal year ended April 24, 2026 (up 14.3% year over year), with a 54.2% gross margin and a -6.1% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open MMED in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2026$3.10B +14.3% YoY
-
Operating Income FY 2026-$190.0M -6.1% margin
-
Net Income FY 2026-$309.0M -10.0% net margin
-
Diluted EPS FY 2026-$1.10 Split-adjusted
-
Free Cash Flow FY 2026-$420.0M -13.5% FCF margin
-
Cash & ST Investments Jul 31, 2026$207.0M Total debt: $59.00M
Annual revenue and net income
3 fiscal years (2024 to 2026), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Apr 24 | Apr 25 | Apr 26 |
|---|---|---|---|
| Revenue | $3.10B | $2.71B | $2.47B |
| Cost of Revenue | $1.42B | $1.19B | $1.03B |
| Gross Profit | $1.68B | $1.53B | $1.44B |
| Research & Development | $448.0M | $436.0M | $437.0M |
| Selling, General & Admin | $1.18B | $1.08B | $1.06B |
| Operating Income | -$190.0M | -$146.0M | -$69.00M |
| EBITDA | -$34.00M | -$3.00M | $60.00M |
| Income Before Tax | -$189.0M | -$147.0M | -$70.00M |
| Income Tax Expense | $128.0M | $52.00M | $38.00M |
| Net Income | -$333.0M | -$213.0M | -$112.0M |
| Basic EPS | -$1.30 | -$0.84 | -$0.44 |
| Diluted EPS | -$1.30 | -$0.84 | -$0.44 |
| Basic Shares Outstanding | 256.6M | 252.8M | 252.8M |
| Diluted Shares Outstanding | 256.6M | 252.8M | 252.8M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-07-31 | 2026-04-24 | 2026-01-23 | 2025-10-24 | 2025-07-25 | 2025-04-25 | 2025-01-24 | 2024-10-25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $843.0M | $837.0M | $790.0M | -- | $723.0M | -- | $687.0M | -- |
| Cost of Revenue | $378.0M | $357.0M | $428.0M | -- | $314.0M | -- | $292.0M | -- |
| Gross Profit | $465.0M | $480.0M | $362.0M | -- | $409.0M | -- | $395.0M | -- |
| Research & Development | $115.0M | $99.00M | $114.0M | -- | $125.0M | -- | $112.0M | -- |
| Selling, General & Admin | $312.0M | $299.0M | $309.0M | -- | $283.0M | -- | $268.0M | -- |
| Operating Income | $5.00M | -$93.00M | -$100.0M | -- | -$13.00M | -- | $21.00M | -- |
| EBITDA | $46.00M | -$54.00M | -- | -- | $26.00M | -- | -- | -- |
| Income Before Tax | $4.00M | -$92.00M | -$99.00M | -- | -$13.00M | -- | $21.00M | -- |
| Income Tax Expense | $4.00M | $93.00M | $12.00M | -- | $3.00M | -- | $28.00M | -- |
| Net Income | $0 | -$185.0M | -$119.0M | -$5.00M | -$19.00M | -$168.0M | -$10.00M | -$5.00M |
| Basic EPS | $0.00 | -- | -$0.47 | -- | -$0.08 | -- | -$0.04 | -- |
| Diluted EPS | $0.00 | -- | -$0.47 | -- | -$0.08 | -- | -$0.04 | -- |
| Basic Shares Outstanding | 281.0M | -- | 252.8M | -- | 252.8M | -- | 252.8M | -- |
| Diluted Shares Outstanding | 281.0M | -- | 252.8M | -- | 252.8M | -- | 252.8M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Apr 24 | Apr 25 |
|---|---|---|
| Cash & Cash Equivalents | $298.0M | $11.00M |
| Cash & Short-Term Investments | $298.0M | $11.00M |
| Accounts Receivable, Net | $200.0M | $570.0M |
| Inventory | $341.0M | $311.0M |
| Other Current Assets | $54.00M | $48.00M |
| Total Current Assets | $1.35B | $939.0M |
| Property, Plant & Equipment, Net | $711.0M | $706.0M |
| Goodwill | $2.26B | $2.25B |
| Intangible Assets | $107.0M | $132.0M |
| Other Non-Current Assets | $147.0M | $150.0M |
| Total Non-Current Assets | $3.28B | $3.26B |
| Total Assets | $4.63B | $4.20B |
| Accounts Payable | $163.0M | $205.0M |
| Deferred Revenue (Current) | $15.00M | $11.00M |
| Other Current Liabilities | -- | $271.0M |
| Total Current Liabilities | $702.0M | $710.0M |
| Deferred Revenue (Non-Current) | $4.00M | $3.00M |
| Other Non-Current Liabilities | $317.0M | $162.0M |
| Total Non-Current Liabilities | $317.0M | $161.0M |
| Total Liabilities | $1.02B | $871.0M |
| Total Debt (incl. Leases) | $53.00M | $67.00M |
| Common Stock | $3.00M | $0 |
| Retained Earnings | -$116.0M | $0 |
| Accumulated Other Comp. Income | -$12.00M | $3.00M |
| Total Stockholders' Equity | $3.61B | $3.33B |
| Total Equity | $3.61B | $3.33B |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-07-31 | 2026-04-24 | 2026-01-23 | 2025-04-25 |
|---|---|---|---|---|
| Cash & Cash Equivalents | $207.0M | $298.0M | $10.00M | $11.00M |
| Cash & Short-Term Investments | $207.0M | $298.0M | $10.00M | $11.00M |
| Accounts Receivable, Net | $180.0M | $200.0M | $653.0M | $570.0M |
| Inventory | $356.0M | $341.0M | $408.0M | $311.0M |
| Other Current Assets | $72.00M | $54.00M | $37.00M | $48.00M |
| Total Current Assets | $1.42B | $1.35B | $1.11B | $939.0M |
| Property, Plant & Equipment, Net | $736.0M | $711.0M | $701.0M | $706.0M |
| Goodwill | $2.25B | $2.26B | $2.26B | $2.25B |
| Intangible Assets | $100.0M | $107.0M | $113.0M | $132.0M |
| Other Non-Current Assets | $152.0M | $147.0M | $146.0M | $150.0M |
| Total Non-Current Assets | $3.30B | $3.28B | $3.23B | $3.26B |
| Total Assets | $4.72B | $4.63B | $4.34B | $4.20B |
| Accounts Payable | $251.0M | $163.0M | $303.0M | $205.0M |
| Deferred Revenue (Current) | $14.00M | $15.00M | $13.00M | $11.00M |
| Other Current Liabilities | -- | -- | $161.0M | $271.0M |
| Total Current Liabilities | $782.0M | $702.0M | $696.0M | $710.0M |
| Deferred Revenue (Non-Current) | $5.00M | $4.00M | $4.00M | $3.00M |
| Other Non-Current Liabilities | $316.0M | $317.0M | $184.0M | $162.0M |
| Total Non-Current Liabilities | $316.0M | $317.0M | $185.0M | $161.0M |
| Total Liabilities | $1.10B | $1.02B | $881.0M | $871.0M |
| Total Debt (incl. Leases) | $59.00M | $53.00M | $61.00M | $67.00M |
| Common Stock | $3.00M | $3.00M | -- | $0 |
| Retained Earnings | -$116.0M | -$116.0M | -- | $0 |
| Accumulated Other Comp. Income | -$14.00M | -$12.00M | $14.00M | $3.00M |
| Total Stockholders' Equity | $3.62B | $3.61B | $3.46B | $3.33B |
| Total Equity | $3.62B | $3.61B | $3.46B | $3.33B |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Apr 24 | Apr 25 | Apr 26 |
|---|---|---|---|
| Net Income | -$317.0M | -$198.0M | -$107.0M |
| Depreciation & Amortization | $156.0M | $143.0M | $129.0M |
| Stock-Based Compensation | $46.00M | $41.00M | $38.00M |
| Change in Inventory | -$29.00M | -$19.00M | $5.00M |
| Operating Cash Flow | -$197.0M | $140.0M | $41.00M |
| Capital Expenditure | -$223.0M | -$193.0M | -$148.0M |
| Free Cash Flow | -$420.0M | -$53.00M | -$107.0M |
| Purchases of Investments | $0 | $0 | -$5.00M |
| Sales & Maturities of Investments | $0 | $0 | $11.00M |
| Investing Cash Flow | -$233.0M | -$193.0M | -$157.0M |
| Financing Cash Flow | $716.0M | $10.00M | $112.0M |
| Net Change in Cash | $287.0M | -$43.00M | -$4.00M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-07-31 | 2026-04-24 | 2026-01-23 | 2025-10-24 | 2025-07-25 | 2025-04-25 | 2025-01-24 | 2024-10-25 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $0 | -$185.0M | -$111.0M | -$5.00M | -$16.00M | -$168.0M | -$7.00M | -$5.00M |
| Depreciation & Amortization | $41.00M | $39.00M | -- | -- | $39.00M | -- | -- | -- |
| Stock-Based Compensation | $10.00M | $8.00M | $11.00M | -- | $9.00M | -- | $11.00M | -- |
| Change in Inventory | -$15.00M | $64.00M | -- | -- | -$30.00M | -- | -- | -- |
| Operating Cash Flow | -$49.00M | -$170.0M | -- | -- | -$141.0M | -- | -- | -- |
| Capital Expenditure | -$41.00M | -$56.00M | -- | -- | -$53.00M | -- | -- | -- |
| Free Cash Flow | -$90.00M | -$226.0M | -- | -- | -$194.0M | -- | -- | -- |
| Investing Cash Flow | -$41.00M | -$56.00M | -- | -- | -$63.00M | -- | -- | -- |
| Financing Cash Flow | $0 | $512.0M | -- | -- | $202.0M | -- | -- | -- |
| Net Change in Cash | -$91.00M | $287.0M | -- | -- | -$2.00M | -- | -- | -- |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Apr 24 | Apr 25 | Apr 26 |
|---|---|---|---|
| Gross Margin | 54.2% | 56.3% | 58.2% |
| Operating Margin | -6.1% | -5.4% | -2.8% |
| Net Profit Margin | -10.7% | -7.8% | -4.5% |
| Return on Equity (ROE) | -9.2% | -6.4% | -- |
| Return on Assets (ROA) | -7.2% | -5.1% | -- |
| Current Ratio | 1.92x | 1.32x | -- |
| Quick Ratio | 1.43x | 0.88x | -- |
| Debt to Equity | 0.01x | 0.02x | -- |
| Revenue Growth (YoY) | +14.3% | +10.0% | -- |
| Gross Profit Growth (YoY) | +9.9% | +6.4% | -- |
| Operating Cash Flow Growth (YoY) | -240.7% | +241.5% | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-07-31 | 2026-04-24 | 2026-01-23 | 2025-10-24 | 2025-07-25 | 2025-04-25 | 2025-01-24 | 2024-10-25 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -8.5% | -9.1% | -9.0% | -- | -- | -6.1% | -- | -- |
| Return on Assets (ROA) | -6.5% | -7.1% | -7.2% | -- | -- | -4.8% | -- | -- |
| Current Ratio | 1.81x | 1.92x | 1.59x | -- | -- | 1.32x | -- | -- |
| Quick Ratio | 1.36x | 1.43x | 1.01x | -- | -- | 0.88x | -- | -- |
| Debt to Equity | 0.02x | 0.01x | 0.02x | -- | -- | 0.02x | -- | -- |
| Revenue Growth (YoY) | +16.6% | -- | +15.0% | -- | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | +13.7% | -- | -8.4% | -- | -- | -- | -- | -- |
| Operating Income Growth (YoY) | -- | -- | -576.2% | -- | -- | -- | -- | -- |